AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Diedtra Henderson
Jan. 28--WASHINGTON -- The Food and Drug Administration yesterday approved the nation's first needle-free insulin, an inhaled powder that analysts expect will become a blockbuster.
Of the 18 million Americans diagnosed with diabetes, about 5 million must take daily shots to regulate blood sugar. Left unchecked, high blood sugar levels can result in a host of ailments -- such as blindness, nerve damage, and heart and kidney disease -- and even comas.
The inhaled insulin, called Exubera, will be marketed by Pfizer Inc. It could be available as early as June. The FDA called it the first major innovation in insulin delivery since commercial sales of the hormone began in the 1920s.
Many diabetics balk at painful insulin injections, and the American Diabetes Association estimates 15 percent of Americans diagnosed with diabetes under-treat themselves.
Exubera "will be a really big deal," predicted Dr. Robert Gabbay, who co-directs Pennsylvania State…